AAAAAA

   
Results: 1-6 |
Results: 6
IMAGING PROLIFERATION IN-VIVO WITH [F-18] FLT AND POSITRON-EMISSION-TOMOGRAPHY
Authors: SHIELDS AF GRIERSON JR DOHMEN BM MACHULLA HJ STAYANOFF JC LAWHORNCREWS JM OBRADOVICH JE MUZIK O MANGNER TJ
Citation: Af. Shields et al., IMAGING PROLIFERATION IN-VIVO WITH [F-18] FLT AND POSITRON-EMISSION-TOMOGRAPHY, Nature medicine, 4(11), 1998, pp. 1334-1336
EFFICACY OF PYRIDOXINE TO AMELIORATE THE CUTANEOUS TOXICITY ASSOCIATED WITH DOXORUBICIN CONTAINING PEGYLATED (STEALTH) LIPOSOMES - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL USING A CANINE MODEL
Authors: VAIL DM CHUN R THAMM DH GARRETT LD COOLEY AJ OBRADOVICH JE
Citation: Dm. Vail et al., EFFICACY OF PYRIDOXINE TO AMELIORATE THE CUTANEOUS TOXICITY ASSOCIATED WITH DOXORUBICIN CONTAINING PEGYLATED (STEALTH) LIPOSOMES - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL USING A CANINE MODEL, Clinical cancer research, 4(6), 1998, pp. 1567-1571
ASSESSMENT OF POTENTIAL DOUBLING TIME (T-POT), ARGYROPHILIC NUCLEOLARORGANIZER REGIONS (AGNOR), AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AS PREDICTORS OF THERAPY RESPONSE IN CANINE NON-HODGKINS-LYMPHOMA
Authors: VAIL DM KISSEBERTH WC OBRADOVICH JE MOORE FM LONDON CA MACEWEN EG RITTER MA
Citation: Dm. Vail et al., ASSESSMENT OF POTENTIAL DOUBLING TIME (T-POT), ARGYROPHILIC NUCLEOLARORGANIZER REGIONS (AGNOR), AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AS PREDICTORS OF THERAPY RESPONSE IN CANINE NON-HODGKINS-LYMPHOMA, Experimental hematology, 24(7), 1996, pp. 807-815
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL
Authors: VAIL DM MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC KISSEBERTH WC LONDON CA OBRADOVICH JE MADEWELL BR RODRIGUEZ CO FIDEL J SUSANECK S ROSENBERG M
Citation: Dm. Vail et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL, Clinical cancer research, 1(10), 1995, pp. 1165-1170
EFFECT OF RECOMBINANT CANINE GRANULOCYTE COLONY-STIMULATING FACTOR ONPERIPHERAL-BLOOD NEUTROPHIL COUNTS IN NORMAL CATS
Authors: OBRADOVICH JE OGILVIE GK STADLERMORRIS S SCHMIDT BR COOPER MF BOONE TC
Citation: Je. Obradovich et al., EFFECT OF RECOMBINANT CANINE GRANULOCYTE COLONY-STIMULATING FACTOR ONPERIPHERAL-BLOOD NEUTROPHIL COUNTS IN NORMAL CATS, Journal of veterinary internal medicine, 7(2), 1993, pp. 65-67
TOXICOSES AND EFFICACY ASSOCIATED WITH ADMINISTRATION OF MITOXANTRONETO CATS WITH MALIGNANT-TUMORS
Authors: OGILVIE GK MOORE AS OBRADOVICH JE ELMSLIE RE VAIL DM STRAW RC SALMON MD KLEIN MK ATWATER SW CIEKOT PE LARUE SM PEASTON A WITHROW SJ
Citation: Gk. Ogilvie et al., TOXICOSES AND EFFICACY ASSOCIATED WITH ADMINISTRATION OF MITOXANTRONETO CATS WITH MALIGNANT-TUMORS, Journal of the American Veterinary Medical Association, 202(11), 1993, pp. 1839-1844
Risultati: 1-6 |